Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tommi Tervonen

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 14, 2018
Assessing Rationality in Discrete Choice Experiments in Health: An Investigation into the Use of Dominance TestsTommi Tervonen, Tabea Schmidt-Ott, Kevin Marsh, et al.
Journal of Clinical Epidemiology|December 27, 2011
Multicriteria benefit-risk assessment using network meta-analysisGert van Valkenhoef, Tommi Tervonen, Jing Zhao, et al.
Advances in Therapy|November 30, 2022
Preferences for Anaemia Treatment Attributes among Patients with Non-Dialysis-Dependent Chronic Kidney DiseaseAna Filipa Alexandre, Antonia Morga, Caitlin Thomas, et al.
Respiratory Medicine|January 2, 2021
Dual-combination maintenance inhaler preferences in asthma and chronic obstructive pulmonary disease: A patient-centered benefit-risk assessmentTommi Tervonen, Fernando J Martinez, Nicola A Hanania, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|August 9, 2020
Response to "Letter to the Editor Regarding: Patient Preferences for Glucagon-like Peptide-1 (GLP-1) Receptor Agonist Treatment of Type 2 Diabetes Mellitus in Japan: A Discrete Choice Experiment"Anne B Brooks, Jakob Langer, Tommi Tervonen, et al.
The Patient|September 27, 2021
Comparing Patient Preferences for Antithrombotic Treatment During the Acute and Chronic Phases of Myocardial Infarction: A Discrete-Choice ExperimentCathy Anne Pinto, Gin Nie Chua, John F P Bridges, et al.
The Journal of Dermatology|December 13, 2023
Treatment preferences of adults and adolescents with alopecia areata: A discrete choice experimentTommi Tervonen, Chiara Whichello, Ernest Law, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|May 20, 2015
Applying Multiple Criteria Decision Analysis to Comparative Benefit-Risk Assessment: Choosing among Statins in Primary PreventionTommi Tervonen, Huseyin Naci, Gert van Valkenhoef, et al.
Pharmacoepidemiology and Drug Safety|July 12, 2017
MCDA swing weighting and discrete choice experiments for elicitation of patient benefit-risk preferences: a critical assessmentTommi Tervonen, Heather Gelhorn, Sumitra Sri Bhashyam, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 10, 2023
Illustrating Emerging Good Practices for Quantitative Benefit-Risk Assessment: A Hypothetical Case Study of Systemic Biologic Treatments for Plaque PsoriasisLeila G Lackey, Xinyi Ng, Jorien Veldwijk, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 14, 2018
Assessing Rationality in Discrete Choice Experiments in Health: An Investigation into the Use of Dominance TestsTommi Tervonen, Tabea Schmidt-Ott, Kevin Marsh, et al.
Journal of Clinical Epidemiology|December 27, 2011
Multicriteria benefit-risk assessment using network meta-analysisGert van Valkenhoef, Tommi Tervonen, Jing Zhao, et al.
Advances in Therapy|November 30, 2022
Preferences for Anaemia Treatment Attributes among Patients with Non-Dialysis-Dependent Chronic Kidney DiseaseAna Filipa Alexandre, Antonia Morga, Caitlin Thomas, et al.
Respiratory Medicine|January 2, 2021
Dual-combination maintenance inhaler preferences in asthma and chronic obstructive pulmonary disease: A patient-centered benefit-risk assessmentTommi Tervonen, Fernando J Martinez, Nicola A Hanania, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|August 9, 2020
Response to "Letter to the Editor Regarding: Patient Preferences for Glucagon-like Peptide-1 (GLP-1) Receptor Agonist Treatment of Type 2 Diabetes Mellitus in Japan: A Discrete Choice Experiment"Anne B Brooks, Jakob Langer, Tommi Tervonen, et al.
The Patient|September 27, 2021
Comparing Patient Preferences for Antithrombotic Treatment During the Acute and Chronic Phases of Myocardial Infarction: A Discrete-Choice ExperimentCathy Anne Pinto, Gin Nie Chua, John F P Bridges, et al.
The Journal of Dermatology|December 13, 2023
Treatment preferences of adults and adolescents with alopecia areata: A discrete choice experimentTommi Tervonen, Chiara Whichello, Ernest Law, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|May 20, 2015
Applying Multiple Criteria Decision Analysis to Comparative Benefit-Risk Assessment: Choosing among Statins in Primary PreventionTommi Tervonen, Huseyin Naci, Gert van Valkenhoef, et al.
Pharmacoepidemiology and Drug Safety|July 12, 2017
MCDA swing weighting and discrete choice experiments for elicitation of patient benefit-risk preferences: a critical assessmentTommi Tervonen, Heather Gelhorn, Sumitra Sri Bhashyam, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 10, 2023
Illustrating Emerging Good Practices for Quantitative Benefit-Risk Assessment: A Hypothetical Case Study of Systemic Biologic Treatments for Plaque PsoriasisLeila G Lackey, Xinyi Ng, Jorien Veldwijk, et al.
Pageof 6